High materiality7/10
Zimmer Biomet price target raised to $100 from $83 at Canaccord
Why it may matterVerify against the original reporting
Upside potential indicated by target increase.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Canaccord Genuity raises ZBH target to $100; posted price $96.55; Analyst Caitlin Cronin.
- Canaccord raises ZBH target to 100; price 96.55.
Key facts
- 01
Target: $100
- 02
Posted price: $96.55
- 03
Analyst firm: Canaccord Genuity
- 04
Analyst: Caitlin Cronin
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.